Get startedLog in
    Picture of Emergent BioSolutions logo

    EBS — Emergent BioSolutions News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Emergent BioSolutions Q3 Revenue USD 293.8 Million

    Picture of Emergent BioSolutions logoEmergent BioSolutions
    06/11/2024 21:05
    Nov 06 (Reuters) - Emergent BioSolutions Q3 adjusted EBITDA USD 105.3 million.
* Q3 net income USD 114.8 million
* Q3 adjusted net income USD 76.2 million

    Recent news on Emergent BioSolutions

    See all news